Symtuza

Active Ingredient(s): Darunavir + Cobicistat + Emtricitabine + Tenofovir Alafenamide
FDA Approved: * July 17, 2018
Pharm Company: * JANSSEN PRODS
Category: HIV / AIDS

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Symtuza Overview

Fixed-dose combinations of antiretrovirals are multiple antiretroviral drugs combined into a single pill, which helps reduce pill burden. They may combine different classes of antiretrovirals (e.g., Atripla) or contain only a single class (e.g., Epzicom). Licensed fixed-dose combinations are shown in the table below. Some are complete single-tablet regimens for the management of HIV/AIDS (the drug is one pill taken once daily); the others must be combined with one or more additional pills to ...

Read more Symtuza Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Fixed-dose_combination_(antiretroviral)

Recent Symtuza Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Darunavir + Cobicistat + Emtricitabine + Tenofovir Alafenamide
  • Tablet: 800mg + 150mg + 200mg + 10mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Symtuza: (1 result)

Sorted by National Drug Code
  • 59676-800 Symtuza Oral Tablet, Film Coated by Janssen Products Lp

Drugs with one or more similar ingredients: (26 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 21 September 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 501 S. Cherry St, Suite 1100, Denver, CO, 80246, USA